You are here: Industry Insights > Mitsubishi

News List

HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration pharmafocusasia
December 11, 2018
HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation....
Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS b3cnewswire.
June 04, 2018
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’), to initiate a Managed Access Program (also known as an Early Access Program) in Europe for edarav
Clinigen, Mitsubishi link for early access programme pharmatimes
May 24, 2018
ALS is an idiopathic neurodegenerative disease in which motor neurons selectively degenerate and vanish, affecting around two in 100,000 people worldwide.
Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS b3cnewswire
May 23, 2018
the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’),
Mitsubishi and Hitachi to use AI to hasten drug R&D pharmaphorum
March 27, 2018
Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.
Mitsubishi and Hitachi to use AI to hasten drug R&D pharmaphorum
March 27, 2018
Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.